Cancer Tests & Diagnosis in Lucknow – Dr. N. A. Siddiqui

A suspected cancer diagnosis can create significant anxiety for patients and families. A scan may show a suspicious mass, a blood test may be abnormal, or symptoms such as unexplained weight loss, persistent bleeding, a lump, a non-healing mouth ulcer or prolonged cough may lead to further investigation.

The important point is that there is no single test that can diagnose every type of cancer.

Cancer diagnosis usually requires a combination of medical history, physical examination, laboratory tests, imaging studies and, in many solid tumors, a biopsy and pathology examination.

If you are looking for Cancer Tests & Diagnosis in Lucknow, Dr. N. A. Siddiqui, Consultant Medical Oncologist & Hematologist, provides oncology consultation for patients with suspected, newly diagnosed, recurrent and advanced cancers.

The aim of cancer evaluation is not simply to answer:

“Is cancer present?”

Doctors may also need to determine:

  • What type of cancer is it?
  • Where did it start?
  • What is the exact pathological subtype?
  • How far has it spread?
  • What stage is the cancer?
  • Are any molecular or biomarker tests required?
  • Which treatment options may be appropriate?

A correct diagnosis is the foundation of an appropriate cancer treatment plan.

How Is Cancer Diagnosed?

Cancer diagnosis usually begins when:

  • A patient develops concerning symptoms
  • A doctor finds an abnormality during examination
  • A screening test is abnormal
  • Imaging identifies a suspicious lesion
  • A laboratory test raises concern
  • Cancer is discovered incidentally during evaluation for another condition

The National Cancer Institute explains that doctors may use laboratory tests, imaging tests and other procedures, and that a biopsy is often the only way to know for certain whether cancer is present.

The exact investigations required depend on the suspected cancer.

A person with a breast lump, for example, requires a different diagnostic pathway from someone with blood in the stool, persistent mouth ulcer or abnormal blood counts.

Cancer Screening vs Cancer Diagnosis

Screening and diagnosis are not the same.

Cancer Screening

Screening is performed in people who do not have symptoms, with the aim of detecting certain cancers or precancerous changes earlier.

Examples include:

  • Mammography
  • Cervical cancer screening
  • Oral cancer screening
  • Colorectal cancer screening
  • Low-dose CT for selected high-risk smokers

Cancer Diagnosis

Diagnostic testing is performed when:

  • Symptoms are present
  • A lump or lesion has been found
  • A screening test is abnormal
  • A scan suggests cancer
  • A previous cancer may have returned

A person with symptoms should therefore not rely only on a routine “cancer screening package.”

They may need focused diagnostic investigations.

Medical History and Physical Examination

Before ordering advanced tests, a doctor usually begins by understanding the patient's clinical history.

Questions may include:

  • When did symptoms start?
  • Are they worsening?
  • Has there been weight loss?
  • Is there bleeding?
  • Is there persistent pain?
  • Does the patient use tobacco?
  • Is there a family history of cancer?
  • Has the patient previously had cancer?
  • Which medicines are being taken?
  • Are there other major medical conditions?

Physical examination may identify abnormalities such as:

  • Lumps
  • Enlarged lymph nodes
  • Breast changes
  • Oral lesions
  • Abdominal swelling
  • Skin changes
  • Organ enlargement
  • Other findings requiring further investigation

These findings help determine which tests are appropriate.

Blood Tests for Cancer Diagnosis

Blood tests can provide useful information during cancer evaluation, but a common misconception is that a routine blood test can either confirm or rule out all cancers.

It cannot.

Laboratory testing may include:

  • Complete blood count
  • Liver-function tests
  • Kidney-function tests
  • Electrolytes
  • Calcium
  • Other biochemical investigations
  • Disease-specific blood tests

Complete Blood Count – CBC

A CBC measures:

  • Hemoglobin
  • White blood cells
  • Platelets
  • Other blood-cell characteristics

Abnormalities may be seen in many conditions.

For example:

  • Low hemoglobin may indicate anemia
  • Abnormal white-cell counts can occur with infection or blood disorders
  • Low platelets may have many causes

Certain blood cancers can cause significant abnormalities in blood counts, but an abnormal CBC alone does not establish a cancer diagnosis.

Further investigations may be required.

Tumor Marker Tests

Tumor markers are substances or biological characteristics that can sometimes provide information about cancer.

Examples used in selected clinical situations include:

  • PSA
  • CA-125
  • CA 19-9
  • AFP
  • CEA
  • Beta-hCG
  • Other disease-specific markers

However, an elevated tumor marker does not automatically mean cancer.

Tumor markers can be elevated in benign conditions, while some patients with confirmed cancer may have normal tumor-marker levels.

This is why tumor markers are usually interpreted alongside:

  • Clinical examination
  • Imaging
  • Pathology
  • Other investigations

Tumor markers may be used differently depending on the disease—for diagnosis support, treatment monitoring or checking for recurrence.

They should not be treated as a universal blood-based cancer screening test.

Imaging Tests Used to Diagnose Cancer

Imaging allows doctors to examine structures inside the body and identify suspicious tumors, enlarged lymph nodes or areas where cancer may have spread.

Different imaging tests answer different questions.

Ultrasound

Ultrasound uses sound waves to create images.

It may be useful in evaluating:

  • Breast abnormalities
  • Abdominal organs
  • Liver lesions
  • Pelvic organs
  • Thyroid nodules
  • Enlarged lymph nodes
  • Other masses

Ultrasound can also help guide certain biopsies.

It does not expose the patient to ionizing radiation.

CT Scan

A CT scan creates detailed cross-sectional images of the body using X-rays and computer processing.

CT scans are commonly used to evaluate areas such as:

  • Chest
  • Abdomen
  • Pelvis
  • Head and neck
  • Other organs

CT may help determine:

  • Tumor size
  • Location
  • Lymph-node involvement
  • Spread to other organs
  • Response to cancer treatment

Contrast material may sometimes be used to improve visualization.

The decision to use contrast depends on the clinical question and patient factors such as kidney function or previous contrast reactions.

MRI

MRI uses strong magnetic fields and radio waves to create detailed images.

MRI can be particularly useful for selected cancers involving:

  • Brain
  • Spine
  • Liver
  • Pelvis
  • Breast
  • Soft tissues
  • Other anatomical areas

MRI does not use X-ray radiation.

Different MRI sequences and contrast agents may be selected depending on the suspected disease.

PET-CT Scan

A PET-CT combines metabolic information from PET imaging with anatomical information from CT.

PET-CT can be useful for selected cancers when doctors need to assess:

  • Extent of disease
  • Lymph-node involvement
  • Distant metastases
  • Treatment response
  • Possible recurrence

However, PET-CT is not necessary for every cancer patient.

Some cancers are better evaluated with CT, MRI or other disease-specific imaging.

A PET-CT should therefore be ordered for a clear clinical reason rather than automatically after every suspected cancer diagnosis.

Endoscopy in Cancer Diagnosis

Some cancers can be investigated by directly examining an organ using an endoscope.

Examples include:

Upper GI Endoscopy

May help evaluate suspected cancers of the:

  • Esophagus
  • Stomach
  • Upper digestive tract

Colonoscopy

May help investigate:

  • Colon cancer
  • Rectal cancer
  • Polyps
  • Blood in stool
  • Persistent bowel symptoms

Bronchoscopy

May help evaluate selected lung or airway abnormalities.

During endoscopy, doctors may obtain tissue for biopsy.

Biopsy – A Key Test for Confirming Cancer

For many solid cancers, biopsy is one of the most important steps in diagnosis.

A biopsy involves removing a sample of tissue or cells so that it can be examined by a pathologist.

Possible biopsy methods include:

  • Needle biopsy
  • Core needle biopsy
  • Fine-needle aspiration in selected situations
  • Endoscopic biopsy
  • Surgical biopsy
  • Bone-marrow biopsy
  • Image-guided biopsy

The appropriate method depends on:

  • Tumor location
  • Size
  • Accessibility
  • Suspected cancer type
  • Amount of tissue required

The National Cancer Institute notes that biopsy is often necessary because imaging and blood tests can strongly suggest cancer but may not be enough to establish a definitive diagnosis.

What Is a Pathology Report?

A pathologist examines biopsy or surgical tissue under a microscope and may perform additional laboratory tests.

The resulting pathology report may contain critical information such as:

  • Whether cancer is present
  • Cancer type
  • Histological subtype
  • Tumor grade
  • Cell characteristics
  • Surgical margins where relevant
  • Lymph-node findings
  • Additional biomarker information

The pathology report can directly influence treatment decisions.

For example, treatment for:

  • Adenocarcinoma
  • Squamous-cell carcinoma
  • Lymphoma
  • Sarcoma

can be very different even if tumors occur in a similar region.

Immunohistochemistry – IHC

Immunohistochemistry, often abbreviated as IHC, uses special antibodies to identify proteins in tumor cells.

IHC may help:

  • Confirm the cancer type
  • Determine the organ of origin
  • Distinguish between tumor subtypes
  • Identify treatment-relevant biomarkers

Examples may include hormone receptors or HER2 testing in breast cancer and other disease-specific markers.

The exact IHC panel should be selected according to the pathological question.

Performing many markers without a clinical reason is not automatically better.

Biomarker and Molecular Testing

Modern cancer diagnosis increasingly extends beyond simply identifying the organ and tumor type.

For selected patients, doctors may also need to understand the cancer's molecular characteristics.

Biomarker testing may examine:

  • Gene mutations
  • Gene rearrangements
  • Protein expression
  • Microsatellite instability
  • Mismatch-repair status
  • Other tumor-specific features

These results may help guide treatment.

For example, selected patients may be evaluated for:

Biomarker testing is particularly relevant in many advanced or metastatic cancers, but it is not required in the same way for every patient.

Internal Link: Precision Oncology in Lucknow

Next-Generation Sequencing – NGS

Next-Generation Sequencing (NGS) can examine many genes or genetic regions at the same time.

NGS may identify molecular alterations with potential treatment relevance.

However, an NGS report must be interpreted carefully.

Results can include:

  • Clinically actionable findings
  • Findings with limited evidence
  • Investigational alterations
  • Variants of uncertain significance

Finding a mutation does not automatically mean that a targeted medicine should be prescribed.

The result should be considered together with:

  • Cancer type
  • Stage
  • Previous treatment
  • Clinical evidence
  • Available approved therapies
  • Patient health

Liquid Biopsy

In selected situations, molecular information may also be obtained from a blood sample using a liquid biopsy.

Liquid biopsy can look for tumor-derived genetic material circulating in blood.

It can be useful when:

  • Tumor tissue is difficult to obtain
  • Additional molecular information is needed
  • A repeat tissue biopsy may be difficult
  • Resistance mechanisms are being investigated

However, liquid biopsy does not replace tissue biopsy in every situation.

A negative liquid-biopsy result can sometimes occur because too little tumor DNA is present in the bloodstream.

Bone Marrow Examination

Blood cancers require a different diagnostic approach from many solid tumors.

A bone-marrow aspiration or biopsy may be needed in suspected or confirmed conditions such as:

  • Leukemia
  • Lymphoma in selected situations
  • Multiple myeloma
  • Other bone-marrow disorders

The sample can be analyzed using:

  • Microscopy
  • Flow cytometry
  • Cytogenetics
  • Molecular tests
  • Other specialized investigations

How Is the Cancer Stage Determined?

After cancer is confirmed, doctors usually determine the extent of disease.

This process is known as staging.

For many cancers, staging considers:

  • Primary tumor
  • Nearby lymph nodes
  • Distant metastases

The exact staging system depends on the cancer type.

Tests used for staging may include:

  • CT
  • MRI
  • PET-CT
  • Bone imaging
  • Endoscopy
  • Surgical findings
  • Pathology

Cancer stage is important because it can influence treatment selection and prognosis.

What If a Scan Suggests Cancer but the Biopsy Is Negative?

This situation requires careful review.

Possible explanations include:

  • The lesion is not cancer
  • The biopsy sampled an incorrect area
  • Too little tissue was obtained
  • The specimen was inadequate
  • Pathology needs further review
  • Additional testing is required

Doctors may consider:

  • Repeat biopsy
  • Different biopsy method
  • Pathology review
  • Repeat or different imaging
  • Short-term follow-up in selected cases

Treatment should not be based on one isolated report when important results do not match the overall clinical picture.

What If the Pathology Report Is Unclear?

Cancer pathology can sometimes be complex.

A second pathology review may be useful when:

  • The diagnosis is rare
  • The tumor subtype is uncertain
  • Different reports disagree
  • Major treatment depends on pathological classification
  • Molecular testing requires additional tissue

Patients should keep pathology blocks and slides available when specialist review has been recommended.

Can Cancer Be Diagnosed Without a Biopsy?

Sometimes cancer may be strongly suspected using imaging, laboratory findings and clinical information, and certain specific clinical situations may be managed differently.

However, for most solid tumors, doctors generally try to obtain pathological confirmation whenever feasible before beginning definitive systemic treatment.

Whether biopsy is safe and necessary depends on the individual situation.

Are Tumor Markers Enough to Diagnose Cancer?

No.

A tumor marker by itself should generally not be considered proof of cancer.

For example, markers can rise because of:

  • Benign medical conditions
  • Inflammation
  • Organ dysfunction
  • Other non-cancer causes

Similarly, a normal tumor marker cannot reliably rule out many cancers.

This is why NCI notes that tumor-marker measurements are generally combined with other tests such as imaging and biopsy.

What Tests Are Needed Before Cancer Treatment Begins?

Once the diagnosis is confirmed, additional testing may be required before therapy.

Depending on the treatment, this may include:

  • CBC
  • Kidney function
  • Liver function
  • ECG
  • Echocardiography
  • Infection screening
  • Biomarker testing
  • Molecular profiling
  • Pregnancy testing where relevant
  • Other disease-specific investigations

These tests help determine whether a treatment is appropriate and can be delivered safely.

Cancer Diagnosis and Second Opinion

Patients may consider another oncology opinion when:

  • The diagnosis is uncertain
  • Pathology is unusual
  • Cancer is rare
  • Multiple treatment options are available
  • Biomarker testing is complex
  • A major treatment is being planned

A second opinion may review:

  • Pathology
  • Imaging
  • Stage
  • Molecular results
  • Proposed treatment

It does not automatically mean the original diagnosis was incorrect.

About Dr. N. A. Siddiqui – Cancer Diagnosis in Lucknow

Dr. N. A. Siddiqui is a Consultant Medical Oncologist & Hematologist practicing in Lucknow.

Qualifications

  • MBBS
  • MD (Medicine)
  • DNB (Medical Oncology)
  • MRCP (UK)
  • PDCR
  • Certificate in Immuno-Oncology
  • ESMO Certified Medical Oncologist

His oncology practice includes evaluation and treatment planning for patients with:

  • Newly diagnosed cancer
  • Advanced and metastatic cancer
  • Recurrent cancer
  • Solid tumors
  • Blood cancers
  • Complex pathology
  • Biomarker-directed treatment requirements

Cancer evaluation may involve coordination with:

  • Pathologists
  • Radiologists
  • Surgical oncologists
  • Radiation oncologists
  • Gastroenterologists
  • Pulmonologists
  • Other relevant specialists

This multidisciplinary approach helps ensure that diagnosis, staging and treatment planning are based on the complete clinical picture.

What Should You Bring to a Cancer Diagnosis Consultation?

Bring all available medical records rather than only the latest report.

Useful documents include:

  • Previous prescriptions
  • Blood tests
  • Ultrasound reports
  • CT reports
  • MRI reports
  • PET-CT reports
  • Imaging CDs
  • Biopsy report
  • Histopathology
  • IHC report
  • Pathology slides or blocks if available
  • Molecular or NGS reports
  • Previous hospital discharge summaries

Complete information can help avoid unnecessary duplication of tests.

Frequently Asked Questions

What is the best test to diagnose cancer?

There is no single best test for every cancer. Diagnosis depends on the suspected cancer and may require imaging, blood tests, endoscopy and biopsy.

Can a blood test confirm cancer?

Routine blood tests alone cannot confirm most cancers. They may identify abnormalities that require further investigation.

Is biopsy always necessary?

For many solid tumors, biopsy is the standard method used to confirm cancer. However, the need and safest method depend on the clinical situation.

Can PET-CT confirm cancer?

PET-CT can identify areas of abnormal metabolic activity and help assess disease extent in selected cancers, but PET-CT findings alone do not always establish the exact pathological diagnosis.

Are tumor markers reliable for detecting cancer?

Tumor markers can be useful in selected cancers, but abnormal results can occur in non-cancerous conditions and normal results do not exclude all cancers.

What happens after a positive biopsy?

The oncologist reviews the cancer type, pathology, stage and relevant biomarkers before discussing treatment options.

Do all cancer patients need molecular testing?

No. Molecular or biomarker testing is most useful when the results may affect diagnosis or treatment selection.

Should I get a second opinion after a cancer diagnosis?

A second opinion may be helpful when diagnosis or treatment is complex, the cancer is rare, several treatments are possible or you want confirmation before starting major therapy.

Consult Dr. N. A. Siddiqui for Cancer Tests & Diagnosis in Lucknow

If an investigation has raised concern about cancer, or if you have already received an abnormal scan or biopsy report, the next step should be a structured medical evaluation rather than random additional testing.

Dr. N. A. Siddiqui provides oncology consultation for patients seeking Cancer Tests & Diagnosis in Lucknow, including review of pathology, imaging, cancer staging, biomarker testing and treatment planning.

Dr. N. A. Siddiqui
Consultant Medical Oncologist & Hematologist

MBBS, MD (Medicine)
DNB (Medical Oncology)
MRCP (UK), PDCR
Certificate in Immuno-Oncology
ESMO Certified Medical Oncologist

Nabeel Cancer Care Centre
529A/142, Sant Kabir Lane, In Front of Farabi Restaurant,
Khurram Nagar, Lucknow

Appointment: +91 7860736600
Website: www.drnasiddiqui.in

BOOK A CANCER DIAGNOSIS CONSULTATION

Medical Disclaimer

This content is intended for general educational purposes only and does not replace individual medical consultation, examination, diagnosis or treatment advice. The investigations required for suspected cancer vary according to symptoms, examination findings, cancer type and individual medical circumstances.